Bristol-Myers Squibb Co
CELG_r0.046USD
+0.001+1.10%
收盤 12/24, 16:00（美東）報價延遲15分鐘
0.00總市值
--本益比TTM
關於 Bristol-Myers Squibb Co 公司
Bristol-Myers Squibb Company is a global biopharmaceutical company. It is engaged in the discovery, development and delivery of transformational medicines for patients facing serious diseases in areas: oncology, hematology, immunology, cardiovascular, neuroscience and other areas. Its growth portfolio includes Opdivo (nivolumab), Opdivo Qvantig (nivolumab and hyaluronidase-nvhy), Yervoy (ipilimumab), Reblozyl (luspatercept-aamt), Opdualag (nivolumab and relatlimab-rmbw), Breyanzi (lisocabtagene maraleucel), Camzyos (mavacamten), Zeposia (ozanimod), Abecma (idecabtagene vicleucel), and Sotyktu (deucravacitinib). Its other growth products include Onureg, Inrebic, and Empliciti. Its legacy portfolio includes Eliquis (apixaban), Revlimid (lenalidomide), Pomalyst/Imnovid (pomalidomide), Sprycel (dasatinib), and Abraxane (paclitaxel albumin-bound particles for injectable suspension). Opdivo (nivolumab) is a fully human monoclonal antibody that binds to the PD-1 on T and NKT cells.
Bristol-Myers Squibb Co簡介
公司代碼CELG_r
公司名稱Bristol-Myers Squibb Co
上市日期Mar 17, 1980
CEOBoerner (Christopher S)
員工數量- -
證券類型Right
年結日- -
公司地址Route 206 And Province Line Road
城市PRINCETON
上市交易所NASDAQ OMX NASDAQ Basic NYSE
國家United States of America
郵編08543
電話16092524621
網址https://www.bms.com
公司代碼CELG_r
上市日期Mar 17, 1980
CEOBoerner (Christopher S)
Bristol-Myers Squibb Co公司高管
名稱
名稱/職務
職務
持股
持股變動
Mr. Benjamin Hickey
Mr. Benjamin Hickey
President - RayzeBio Organization, Member of the Leadership Team
President - RayzeBio Organization, Member of the Leadership Team
--
--
Dr. Julia A. Haller, M.D.
Dr. Julia A. Haller, M.D.
Independent Director
Independent Director
--
--
Ms. Lynelle Hoch
Ms. Lynelle Hoch
President, Cell Therapy Organization, Member of the Leadership Team
President, Cell Therapy Organization, Member of the Leadership Team
--
--
Ms. Phyllis R. Yale
Ms. Phyllis R. Yale
Independent Director
Independent Director
--
--
Mr. Greg Scott Meyers
Mr. Greg Scott Meyers
Executive Vice President, Chief Digital and Technology Officer, Member of the Leadership Team
Executive Vice President, Chief Digital and Technology Officer, Member of the Leadership Team
--
--
Ms. Amanda Poole
Ms. Amanda Poole
Executive Vice President, Chief People Officer, Member of the Leadership Team
Executive Vice President, Chief People Officer, Member of the Leadership Team
--
--
Dr. Manuel Hidalgo Medina, M.D., Ph.D.
Dr. Manuel Hidalgo Medina, M.D., Ph.D.
Independent Director
Independent Director
--
--
Mr. Robert Plenge, M.D., Ph.D.
Mr. Robert Plenge, M.D., Ph.D.
Executive Vice President, Chief Research Officer, Head of Research, Member of the Leadership Team
Executive Vice President, Chief Research Officer, Head of Research, Member of the Leadership Team
--
--
Dr. Karen H. Vousden, Ph.D.
Dr. Karen H. Vousden, Ph.D.
Independent Director
Independent Director
--
--
Mr. David V. Elkins
Mr. David V. Elkins
Executive Vice President, Chief Financial Officer, Member of the Leadership Team
Executive Vice President, Chief Financial Officer, Member of the Leadership Team
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Benjamin Hickey
Mr. Benjamin Hickey
President - RayzeBio Organization, Member of the Leadership Team
President - RayzeBio Organization, Member of the Leadership Team
--
--
Dr. Julia A. Haller, M.D.
Dr. Julia A. Haller, M.D.
Independent Director
Independent Director
--
--
Ms. Lynelle Hoch
Ms. Lynelle Hoch
President, Cell Therapy Organization, Member of the Leadership Team
President, Cell Therapy Organization, Member of the Leadership Team
--
--
Ms. Phyllis R. Yale
Ms. Phyllis R. Yale
Independent Director
Independent Director
--
--
Mr. Greg Scott Meyers
Mr. Greg Scott Meyers
Executive Vice President, Chief Digital and Technology Officer, Member of the Leadership Team
Executive Vice President, Chief Digital and Technology Officer, Member of the Leadership Team
--
--
Ms. Amanda Poole
Ms. Amanda Poole
Executive Vice President, Chief People Officer, Member of the Leadership Team
Executive Vice President, Chief People Officer, Member of the Leadership Team
--
--
收入明細
由於公司未披露，未能獲取相關數據
由於公司未披露，未能獲取相關數據
業務
地區
由於公司未披露，未能獲取相關數據
股東統計
更新時間: 11月22日 週六
更新時間: 11月22日 週六
持股股東
股東類型
持股股東
持股股東
佔比
其他
100.00%
持股股東
持股股東
佔比
其他
100.00%
股東類型
持股股東
佔比
其他
100.00%
機構持股
更新時間: 12月8日 週一
更新時間: 12月8日 週一
報告期間
機構數
持股數
持股佔比
持股變動
2025Q4
32
423.55K
0.00%
--
2025Q3
33
423.55K
0.00%
-91.51K
2025Q2
34
515.06K
0.00%
+32.24K
2025Q1
32
482.82K
0.00%
-636.30K
2024Q4
32
943.61K
0.00%
+342.07K
2024Q3
31
601.53K
0.00%
+90.03K
2024Q2
30
511.50K
0.00%
+113.76K
2024Q1
32
397.74K
0.00%
-298.70K
2023Q4
30
495.62K
0.00%
-40.30K
2023Q3
30
535.93K
0.00%
-7.05K
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
International Assets Investment Management, LLC
175.00
0%
+175.00
--
Jun 30, 2024
Transcend Capital Advisors, LLC
109.17K
0%
--
--
Jun 30, 2025
Davenport Asset Management
83.97K
0%
--
--
Jun 30, 2025
BofA Global Research (US)
51.83K
0%
+10.00
+0.02%
Jun 30, 2025
Purkiss Capital Advisors LLC
26.45K
0%
--
--
Jun 30, 2025
Two Sigma Investments, LP
21.99K
0%
-3.69K
-14.36%
Jun 30, 2025
MainStreet Advisors
20.00K
0%
--
--
Jun 30, 2025
Watts Gwilliam & Co LLC
20.00K
0%
--
--
Jun 30, 2025
Private Advisor Group LLC
15.00K
0%
--
--
Jun 30, 2025
Dimensional Fund Advisors, L.P.
9.21K
0%
--
--
Jun 30, 2025
查看更多
持股ETF
機構名稱
佔比
暫無數據
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據
常見問題
Bristol-Myers Squibb Co的前五大股東是誰？
Bristol-Myers Squibb Co的前五大股東如下：
International Assets Investment Management, LLC持有股份：175.00佔總股份比例：0.00%。
Transcend Capital Advisors, LLC持有股份：109.17K佔總股份比例：0.00%。
Davenport Asset Management持有股份：83.97K佔總股份比例：0.00%。
BofA Global Research (US)持有股份：51.83K佔總股份比例：0.00%。
Purkiss Capital Advisors LLC持有股份：26.45K佔總股份比例：0.00%。
International Assets Investment Management, LLC持有股份：175.00佔總股份比例：0.00%。
Transcend Capital Advisors, LLC持有股份：109.17K佔總股份比例：0.00%。
Davenport Asset Management持有股份：83.97K佔總股份比例：0.00%。
BofA Global Research (US)持有股份：51.83K佔總股份比例：0.00%。
Purkiss Capital Advisors LLC持有股份：26.45K佔總股份比例：0.00%。
Bristol-Myers Squibb Co的前三大股東類型是什麼？
Bristol-Myers Squibb Co 的前三大股東類型分別是：
其他
其他
有多少機構持有Bristol-Myers Squibb Co(CELG_r)的股份？
截至2025Q4，共有32家機構持有Bristol-Myers Squibb Co的股份，合計持有的股份價值約為423.55K，占公司總股份的--% 。與2025Q3相比，機構持股有所增加，增幅為--。
哪個業務部門對Bristol-Myers Squibb Co的收入貢獻最大？
在--，--業務部門對Bristol-Myers Squibb Co的收入貢獻最大，創收--，占總收入的--% 。
